Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.32 USD | +1.78% |
|
-2.54% | +49.61% |
07-03 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 1000 | CI |
07-03 | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 600 Health Care | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.61% | 1.98B | |
+17.25% | 45.34B | |
+42.10% | 40.42B | |
-10.43% | 37.92B | |
+32.31% | 31.75B | |
-8.98% | 27.71B | |
+12.61% | 26.52B | |
+43.82% | 13.96B | |
+31.14% | 12.44B | |
-7.14% | 11.26B |
- Stock Market
- Equities
- PTGX Stock
- News Protagonist Therapeutics, Inc.
- Transcript : Protagonist Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 02